TGF-β1 in allograft and long-term renal function

Journal of Central South University (Medical Sciences)

Volumn 29, Issue 6, 2004, Pages 700-703

  Wang, Fing Xian ^a   Huang, Xiu Ying ^a   Wang, An Jing ^a   Huang, Chi Bing ^a   Fan, Ming Qi ^a   Zhang, Yin Pu ^a  

^a THIRD MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Kidney; Nephropathy; TGF 1; Transplantation

Indexed keywords

TGFB1 PROTEIN, HUMAN; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA1;

ARTICLE; HUMAN; KIDNEY DISEASE; KIDNEY TRANSPLANTATION; NEEDLE BIOPSY; PATHOLOGY; PATHOPHYSIOLOGY; POSTOPERATIVE COMPLICATION; TIME; URINE;

BIOPSY, NEEDLE; HUMANS; KIDNEY DISEASES; KIDNEY TRANSPLANTATION; POSTOPERATIVE COMPLICATIONS; TIME FACTORS; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA1;

EID: 33846450676     PISSN: 16727347     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (8)

1. Morales JM, Andres A, Rengel M, et al. Influence of cyclosporin, tacrolimus and rapamycin on renal function and arterial hypertension after renal transplantation [J]. Nephrol Dial Transplant, 2001, 16(1):121-124. (Pubitemid 32492523)
2. Densem CG, Mutlak AS, Pravica V, et al. A novel polymorphism of the gene encoding furin, a TGF-β1 activator, and the influence on cardiac allograft vasculopathy formation [J]. Transp Immunol, 2004, 13(3):185-190. (Pubitemid 39307045)
3. Abdel WN, Weston BS, Roberts T, et al. Connective tissue growth factor and regulation of the mesangial cell cycle: role in cellular hypertrophy [J]. J Am Soc Nephrol, 2002, 13(10):2437-2445.
4. Citterio F, Pozzetto U, Romagnoli J, et al. Plasma levels of transforming growth factor β1 in renal transplant recipients receiving different immunosuppressive regimens [J]. Transplant Proc, 2004, 36(3):698-699. (Pubitemid 38534364)
5. Paul LC. Chronic allograft nephropathy: An update [J]. Kidney Int, 1999, 56(3):783-793.
6. Amann K, Koch Ahofstetter J, et al. Glomerulosclerosis and progression: effect of subantihypertensive doses of alpha and beta blockers [J]. Kidney Int, 2001, 60(4):1309-1323. (Pubitemid 32962590)
7. Houlihan CA, Akdeniz A, Tsalamandris C, et al. Urinary transforming growth factor-beta excretion in patients with hypertension, type 2 diabetes, and elevated albumin excretion rate: effects of angiotensin receptor blockade and sodium restriction [J]. Diabetes Care, 2002, 25(6):1072-1077. (Pubitemid 41110496)
8. Woo YC, Jong AH, Young KW, et al. Synergistic effects of mycophenolate mofetil and losartan in a model of chronic cyclosporine nephropathy [J]. Transplantation, 2003, 75(3):309-315.